Partners

Partners for biotech venture creation and activation.

WBV collaborates with selected partners who bring tangible capabilities across investment, incubation, scientific evaluation, company creation, business development, licensing, commercialization, and strategic transactions.

Selective Collaboration

Execution-focused partnerships across venture creation and biotech development.

Our partner model is focused on execution, not broad affiliation. WBV works selectively with organizations that can contribute meaningful capabilities, strategic coordination, and operational value across biotech therapeutics opportunities.

Strategic Partner

Viva BioInnovator

Viva BioInnovator is an investment and incubation partner supporting early-stage biotech company development, venture formation, and innovation acceleration.

Strategic Partner

Protheragen

Protheragen is a biotech innovation and development partner supporting early-stage company development, translational execution, and venture-building activities.

Strategic Partner

Admera Health

Admera Health brings precision medicine, genomic, and molecular capabilities that may support biomarker-driven biotech development and translational strategy.

Collaboration Areas

Coordinated capabilities across biotech venture execution.

Investment and incubation

Venture creation and company building

Scientific and technical evaluation

Business development and strategic partnering

Licensing and commercialization

Academic venture creation

Syndicate formation

Interested in partnering on biotech venture creation, incubation, investment, or activation?

WBV works selectively with aligned organizations capable of contributing meaningful scientific, strategic, operational, or investment value.